Article By:
Vivian Lewis
Wednesday, August 13, 2014 2:58 PM EDT
Today's Wall Street Journal reports that Glaxo's CEO Sir Andrew Witty also faces pressure to clean up its business lines and boost results. Triggering the dissent is the latest bribery scandal eruption, over Syria.